Cyclosporin pharmacokinetics in paediatric transplant recipients

Clinical Pharmacokinetics

Volumn 32, Issue 6, 1997, Pages 481-495

  Cooney, Gerard F ^a   Habucky, Karen ^b   Hoppu, Kalle ^c  

^a TEMPLE UNIVERSITY   (United States)

^b Sandoz Pharma Ltd   (Switzerland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PANCREAS ENZYME;

AGE; AREA UNDER THE CURVE; BODY SIZE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG METABOLISM; GRAFT REJECTION; HEART GRAFT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE ABSORPTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVER TRANSPLANTATION; MICROEMULSION; ORAL DRUG ADMINISTRATION; PEDIATRICS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW;

EID: 0031009246     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199732060-00004     Document Type: Review

References (81)

1. Fine RN. Renal transplantation of the infant and young child and the use of paediatric cadaver kidneys for transplantation in paediatric and adult recipients. Am J Kidney Dis 1988; 12: 1-10
2. Addonizio LJ. Cardiac transplantation in the paediatric patient. Prog Cardiovasc Dis 1990; 33: 19-34
3. Paradis KJG, Freese DK, Sharp HL. A paediatric perspective on liver transplantation. Pediatr Clin North Am 1988; 35: 409-33
4. Kahn D, Esquivel CO, Makowka L, et al. Causes of death after liver transplantation in children treated with cyclosporine And steroids. Clin Transplant 1989; 3: 150-5
5. Michler RE, Fox IJ, Hardy MA. Paediatric organ transplantation: History, current status and important trends. Sandoz Transplantation Series Monograph - 1992. East Hanover (NJ): Sandoz Pharmaceutical Corp., 1992
6. Ettenger RB, Rosenthal JT, Mark J, et al. Long term results with cyclosporine immune suppression iin pediatric codaver renal transplantation. Transplant Proc 1991 Feb; 23: 1011-2
7. Laine J, Hoppu K, Holmberg C. Renal allograft function and histology in children on triple immunosupression based on individual pharmacokinetically determined cyclosporine administration. Transplant Proc 1994; 26 (5): 2775-6
8. Najarian JS, Frey DJ, Matas AJ, et al. Renal transplantation in infants. Ann Surg 1990; 212: 353-67
9. UNOS. Paediatric graft and survival data released. UNOS Update 1991; 7: 5
10. Belle SH, Detre KM, Beringer KC, et al. Liver transplantation in the United States. In: Terasaki PI, editor. Clinical transplants: 1990. Los Angeles: UCLA Tissue Typing Laboratory, 1991: 11-9
11. Kriett JM, Kaye MP. The registry of the International Society for Heart and Lung Transplantation: eighth official report - 1991. J Heart Lung Transplant 1991; 10: 491-8
12. Broyer M, Gagnadoux MF, Guest G, et al. Triple therapy including cyclosporine A verses conventional regimen: a randomized prospective study in paediatric kidney transplantation. Transplant Proc 1987; 19: 3582-5
13. MacDonell Jr RC, Johnson K, Ritchie R, et al. Paediatric renal transplantation results are improved with triple drug therapy with cyclosporine A, azathioprine, and prednisone. Transplant Proc 1989; 21: 1701-4
14. Klare B, Strom TM, Hahn H, et al. Remarkable long-term prognosis and excellent growth in kidney-transplant children under cyclosporine A monotherapy. Transplant Proc 1991; 23: 1013-7
15. Margarit C, Martinez-Ibanez V, Tormo R, et al. Maintainence immunosuppression without steroids in paediatric liver transplantion. Transplant Proc 1989; 21: 2230-1
16. Hodson EM, Knight JF, Sheil AGR, et al. Cyclosporine A as sole immunosuppressive agent for renal transplantation in children: effect of catch-up growth. Transplant Proc 1989; 21: 1687-92
17. Reisman L, Lieberman KV, Burrows L, et al. Follow-up of cyclosporine A-treated paediatric renal allograft recipients after cessation of prednisone. Transplantation 1990; 49: 76-80
18. Hilbrands LB, Hoitsma AJ, Koene KA. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation. Transplantation 1996; 61 (7): 1038-46
19. Hoyer PF, Krohn HP, Offner G, et al. Renal function after kidney transplantation in children. Transplantation 1987; 43: 489-93
20. Berg UB, Bohlin A-B. Renal transplantation in children: renal function follow-up of cyclosporine A-treated children. Transplant Proc 1990; 22: 160-1
21. Andrews WA, Arant BS, Fyock B, et al. The effect of cyclosporine A on long-term renal function in paediatric liver transplant recipients. Transplant Proc 1991; 23: 1452-3
22. Sommerauer JF, Howard J, Grant O. Renal function following liver transplantation in children. Transplant Proc 1991; 23: 1466-8
23. Lawless S, Ellis D, Thompson A, et al. Mechanisms of hypertension during and alter orthoptic liver transplantation in children. J Pediatr 1989; 115: 372-9
24. Jaffe SJ, Aranda JV, editors. Paediatric pharmacology. Therapeutic principles in practice. 2nd ed, Philadelphia: WB Saunders, 1992
25. Radde IC, MacLeod SM, editors. Paediatric pharmacology and therapeutics. 2nd ed, St Louis: Mosby Press, 1993: 57-86
26. Ohlman S, Lindholm A, Hagglund H, et al. On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation. Eur J Clin Pharmacol 1993; 44: 265-9
27. Motil KJ. Development of the gastrointestinal tract. In: Wyllie R, Hyams JS, editor. Paediatric gastrointestinal disease. Philadelphia; WB Saunders Co., 1993: 3-15
28. Venkalaramanan R, Habucky K, Burckart GJ, et al. Clinical pharmacokinetics in organ transplant patients. Clin Pharmacokinet 1989; 16: 134-61
29. Whitington P, Edmond J, Whitington S, et al. Small-bowel length and the dose of Cyclosporine A in children after liver transplantation. N Engl J Med 1990; 322: 733-8
30. Winsberg B, Perel J, HurWic M, et al. Imipramine protein binding and pharmacokinetics in children. In: Forrest I, Carr C, Usdin E, editors. The phenothiazines and structurally related drugs. New York: Raven Press, 1974: 425-31
31. Morselli PL, Franco-Morselli R, Bossi R. Clinical pharmacokinetics in newborns and infants: age-related differences and therapeutic implications. Clin Pharmacokinet 1980; 5: 485-527
32. Klotz U. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications. Clin Pharmacokinet 1976; 1: 204-18
33. Appel GB. Lipid abnormalities in renal disease. Kidney Int 1991; 39: 169-83
34. Hamberger C, Urien S, Barre J, et al. Distribution of Cyclosporine A between blood cells and plasma of cardiac and renal transplant recipients. Ther Drug Monit 1988; 10: 28-33
35. Antikainen M, Holmberg C. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis. Clin Nephrol 1994; 41: 284-9
36. Becker DM, Chamberlain B, Schwank R, et al. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. Am J Mal 1988; 85: 632-8
37. Awni WM, Heim-Dulhoy K, Kasiske BL. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant recipients. Transplant Proc 1990; 22: 1193-6
38. Natha DG, Oski FA, editors. Hematology in infancy and childhood. Philadelphia: WB Saunders Co., 1987: 266
39. Zaghloul I, Ptachicinski RJ, Burckart GJ, et al. Blood protein binding of Cyclosporine A in transplant patients. J Clin Pharm 1987; 27: 240-2
40. Radde IC, Kalow W. Drug biotransformation and its development. In: Radde IC, MacLeod SM, editors. Paediatric pharmacology and therapeutics. 2nd ed. St Louis: Mosby Press, 1993: 57-86
41. Harmon WE, Sullivan EK. Cyclosporine A dosing and its relationship to outcome in paediatric renal transplantation. Kidney Int 1993; 44 Suppl. 43: 550-5
42. Bleyer W. Antineoplastic agents. In: Jaffe SJ, editor. Paediatric pharmacology: therapeutic principles in practice. 1st ed. New York: Grune & Stratton, 1980: 349-77
43. Holford NHG. A size standard for pharmacokinetics. Clin Pharmacokinet 1996; 30 (5): 329-32
44. Cooney GF, Dunn SP, Kaiser B, et al. Oral Cyclosporine A pharmacokinetics in paediatric renal and liver transplant recipients. Transplant Proc 1994; 26 (5): 2779-80
45. Ptachcinski RJ, Venkataramanan R, Burckart GJ. Clinical pharmacokinetics of cyclosporine A. Clin Pharmacokinet 1986a; 11: 107-32
46. Frey FJ, Horber FF, Frey BM. Trough level and concentration time curves of Cyclosporine A in patients undergoing renal transplantation. Clin Pharmacol Ther 1988; 43: 55-62
47. Ptachcinski R, Burckart G, Rosenthal J, et al. Cyclosporine A pharmacokinetics in children following cadaveric renal transplantation. Transplant Proc 1986b; 18 (4): 766-7
48. Neiberger R, Weiss R, Gomez M, et al. Elimination kinetics of Cyclosporine A following oral administration to children with renal transplants. Transplant Proc 1987; 19: 1525
49. Bauina WD, Veremis SA, Maddux MS, et al. Optimizing Cyclosporine A use in paediatric patients by measuring pretransplant blood levels. Transplant Proc 1987; 19 (1): 1709-10
50. Humbert H, Guest G, Said MB, et al. Steady state pharmacokinetics of cyclosporine in renal: transplant patients: does an influence of age or bodyweight exist? Transplant Proc 1994; 26: 2791-7
51. Jacqz-Aigrain E, MontSs C, Brun P, Loirat C. Cyclosporine A pharmacokinetics in nephrotic and kidney transplant paediatric patients. Eur J Clin Pharmacol 1994; 47: 61-5
52. Venkataramanan R, Burckart G, Ptachcinski R, et al. Cyclosporine A pharmacokinetics in heart transplant patients. Transplant Proc 1986; 18 (4): 768-70
53. Burckart G, Venkataramanan R, Fricker F, et al. Cyclosporine A kinetics in paediatric patients with congestive heart failure. Transplant Proc 1987; 19 (1): 1528-29
54. Burckart G, Starzl T, Williams L, et al. Cyclosporine A monitoring and pharmacokinetics in paediatric liver transplant patients. Transplant Proc 1985; 17 (1): 1172-5
55. Burckart G, Venkataramanan R, Ptachcinski R, et al. Cyclosporine absorption following orthotopic liver transplantation. J Clin Pharmacol 1986; 26: 647-51
56. Sokol RJ, Johnson KE, Karrer FM, et al. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin K. Lancet 1991; 338 (8761): 212-214
57. Dunn SP, Cooney GF, Kulinsky A, et al. Absorption characteristics of a microemulsion formulatiion of cyclosporine A in de novo paediatric liver transplant recipients. Transplantation 1995; 60 (12): 1438-42
58. Yee G, Lennon T, Gmur D, et al. Age-dependent Cyclosporine A: pharmacokinetics in marrow transplant recipients. Clin Pharmacol Ther 1986; 40 (4): 438-43
59. Yee G, McGuire T, Gmur D, et al. Blood Cyclosporine A pharmacokinetics in patients undergoing marrow transplantation. Transplantation 1988; 46 (3): 399-402
60. Ptachcinski RJ, Venkataramanan R, Rosenthal JT, et al. Cyclosporine kinetics in renal transplantation. Clin Pharmacol Ther 1985; 38: 296-300
61. Heifets M, Cooney GF, Shaw LM, et al. Diurnal variation of cyclosporine A clearance in stable renal transplant recipients receiving continuous infusion. Transplantation 1995; 60 (12): 1615-7
62. Hoppu K, Koskimies O, Holmberg C, et al. Pharmacokinetically determined Cyclosporine A dosage in young children. Pediatr Nephrol 1991a; 5: 1-4
63. Lin CY, Lee SF. Comparison of pharmacokinetics between CsA capsules and Sandimmun Neoral in paediatric patients. Transplant Proc 1994; 26 (5): 2973-4
64. Bokenkamp A, Offner G, Hover PF, et al. Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring. Paediatr Nephrol 1995; 9 (2): 196-8
65. Ettenger RE, Smith HT, Cooney GF, et al. Use of Neural in pediatric renal transplantation. Transplanl Proc 1996; 28 (4): 2257-8
66. Alberti D, Wallemacq P, Falchetti D, et al. Microemulsion formulation of cyclosporine in paediatric liver transplantation. Transplantation 1996; 61 (3): 512-4
67. Hoppu K, Jalanko H, Laine J, et al. Comparison of conventional oral cyclosporine and cyclosporine microemulsion formulations in children with a liver transplant. Transplantation 1996; 62: 1-6
68. Dunn SP, Cooney GF, Sommerauer J, et al. Enhanced bioavailability of Neoral compared to Sandimmune in paediatric stable liver transplant patients. Transplantalion 1997. In press
69. Mehta MU, Venkataramanan R, Burckart GJ, et al. Effect of bile in Cyclosporine absorption in transplant patients. Br J Clin Pharm 1988; 25: 579-84
70. Kehrer BH, Whitington PF, Black DD. The effect of Roux-en-Y biliary enterostomy on the absorption of Cyclosporine A: relevance to poor drug bioavailability in children after orthotopic liver transplantation. Transplant Proc 1988; 20 (2): 523-8
71. Tjia JF, Webber IR, Back DJ. Cyclosporin Metabolism by the Gastrointestinal Mucosa. Br J Clin Pharmacol 1991; 31 (3): 344-6
72. Webber IR, Peters WH, Back DJ. Cydosporin metabolism by human gastrointestinal mucosal microsomes. Br J Clin Pharmacol 1992; 33 (6): 661-4
73. Mancel-Grosso V, Bertault-Peres P, Barthelemy A, et al. Pharmacokinetics of Cyclosporine A in bilaveral lung transplantation candidates with cystic fibrosis. Transplant Proc 1990; 22 (4): 1706-7
74. Awni WM, Sawchuk RJ. The pharmacokinetics of Cyclosporine A II: blood plasma distribution and binding studies. Drug Metab Dispos 1985; 13 (2): 133-8
75. Newberger J, Kahan BD. Cyclosporine A pharmacokinetics in man. Transplant Proc 1983; 15: 2413-5
76. Jain AB, Fung JJ, Tzakis AG, et al. Comparative study of Sandimmune and FK 506 dosage requirements in adult and paediatric orthotopic liver transplant patients. Transplant Proc 1991; 23 (6): 2763-6
77. Hoppu K, Koskimies O, Holmberg C, et al. Evidence for prehepatic metabolism of oral Cyclosporine A in children. Br J Clin Pharmacol 1991b; 32: 477-81
78. Paradis K, Al Edreesi M, St-Vil D, et al. Cyclosporine kinetics in paediatric liver transplant recipients: impact of dose fractionation on true glomerular filtration rate. Transplant Proc 1994; 26 (5): 2777-8
79. Laine J, Krogerus L, Fyhrquist F, et al. Renal function and histopathologic changes in children after liver transplantation. J Paediatr 1994b; 125 (6): 863-9
80. Cooney GF, Lum BL, Meligeni JA, et al. Pharmacokinetics of a microemulsion formulation of Cyclosporine in paediatric liver transplant recipients. Transplant Proc 1996; 28: 2270-72
81. Masri MA, Dhawan VS, Hayes K, et al. Cyclosporine dosage-according to pharmacokinetic profiles leads to better graft and patient survival rates and a decrease in Cyclosporine consumption. Transplant Proc 1992; 24 (5): 1718-20